View in EDS HTML Full Text PDF Full Text

SLC13A3 is a major effector downstream of activated β-catenin in liver cancer pathogenesis.

Saved in:
Bibliographic Details
Title: SLC13A3 is a major effector downstream of activated β-catenin in liver cancer pathogenesis.
Authors: Zhao W; School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China., Wang X; Department of Nutritional Sciences and Toxicology, University of California Berkeley, Berkeley, CA, USA.; Cancer Biology Program, University of Hawaii Cancer Center, Honolulu, HI, USA., Han L; Tianjin State Key Laboratory of Modern Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China., Zhang C; Department of Colorectal Surgery, Tianjin Union Medical Center, Tianjin, China., Wang C; Tianjin State Key Laboratory of Modern Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China., Kong D; Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics, School of Pharmacy, Tianjin Medical University, Tianjin, China., Zhang M; School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China., Xu T; School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China., Li G; School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China., Hu G; School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China., Luo J; School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China., Yee SW; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA, USA., Yang J; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA, USA., Stahl A; Department of Nutritional Sciences and Toxicology, University of California Berkeley, Berkeley, CA, USA., Chen X; Cancer Biology Program, University of Hawaii Cancer Center, Honolulu, HI, USA. xinchen3@hawaii.edu.; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA, USA. xinchen3@hawaii.edu., Zhang Y; School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China. youcai.zhang@tju.edu.cn.
Source: Nature communications [Nat Commun] 2024 Aug 30; Vol. 15 (1), pp. 7522. Date of Electronic Publication: 2024 Aug 30.
Publication Type: Journal Article
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39215042
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: SLC13A3 is a major effector downstream of activated β-catenin in liver cancer pathogenesis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Zhao+W%22">Zhao W</searchLink>; School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Wang+X%22">Wang X</searchLink>; Department of Nutritional Sciences and Toxicology, University of California Berkeley, Berkeley, CA, USA.; Cancer Biology Program, University of Hawaii Cancer Center, Honolulu, HI, USA.<br /><searchLink fieldCode="AU" term="%22Han+L%22">Han L</searchLink>; Tianjin State Key Laboratory of Modern Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Zhang+C%22">Zhang C</searchLink>; Department of Colorectal Surgery, Tianjin Union Medical Center, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Wang+C%22">Wang C</searchLink>; Tianjin State Key Laboratory of Modern Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Kong+D%22">Kong D</searchLink>; Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics, School of Pharmacy, Tianjin Medical University, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Zhang+M%22">Zhang M</searchLink>; School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Xu+T%22">Xu T</searchLink>; School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Li+G%22">Li G</searchLink>; School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Hu+G%22">Hu G</searchLink>; School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Luo+J%22">Luo J</searchLink>; School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Yee+SW%22">Yee SW</searchLink>; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Yang+J%22">Yang J</searchLink>; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Stahl+A%22">Stahl A</searchLink>; Department of Nutritional Sciences and Toxicology, University of California Berkeley, Berkeley, CA, USA.<br /><searchLink fieldCode="AU" term="%22Chen+X%22">Chen X</searchLink>; Cancer Biology Program, University of Hawaii Cancer Center, Honolulu, HI, USA. xinchen3@hawaii.edu.; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA, USA. xinchen3@hawaii.edu.<br /><searchLink fieldCode="AU" term="%22Zhang+Y%22">Zhang Y</searchLink>; School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China. youcai.zhang@tju.edu.cn.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2024 Aug 30; Vol. 15 (1), pp. 7522. <i>Date of Electronic Publication: </i>2024 Aug 30.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39215042
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41467-024-51860-2
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 7522
    Titles:
      – TitleFull: SLC13A3 is a major effector downstream of activated β-catenin in liver cancer pathogenesis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Zhao W
      – PersonEntity:
          Name:
            NameFull: Wang X
      – PersonEntity:
          Name:
            NameFull: Han L
      – PersonEntity:
          Name:
            NameFull: Zhang C
      – PersonEntity:
          Name:
            NameFull: Wang C
      – PersonEntity:
          Name:
            NameFull: Kong D
      – PersonEntity:
          Name:
            NameFull: Zhang M
      – PersonEntity:
          Name:
            NameFull: Xu T
      – PersonEntity:
          Name:
            NameFull: Li G
      – PersonEntity:
          Name:
            NameFull: Hu G
      – PersonEntity:
          Name:
            NameFull: Luo J
      – PersonEntity:
          Name:
            NameFull: Yee SW
      – PersonEntity:
          Name:
            NameFull: Yang J
      – PersonEntity:
          Name:
            NameFull: Stahl A
      – PersonEntity:
          Name:
            NameFull: Chen X
      – PersonEntity:
          Name:
            NameFull: Zhang Y
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 30
              M: 08
              Text: 2024 Aug 30
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2041-1723
          Numbering:
            – Type: volume
              Value: 15
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Nature communications
              Type: main
ResultId 1